March 23, 2026 - ET (Eastern Time, GMT-05:00)
- Stephen Rivera - Former Vice President, Global Technical Accounting Advisory Services & Policy, Johnson & Johnson
The CFO role is rapidly evolving from traditional financial oversight to being a strategic, data-driven business partner focused on organizational impact and performance.
Prominent CFOs will share examples of organizational initiatives and how these actions are reshaping finance to enhance business performance and growth.
CPE Credits Available: 1.2
- Nick Cernese - Americas Healthcare & Life Sciences Finance Transformation Leader, Ernst & Young
- SEC Remarks
- FASB Remarks
- Town Hall Q&A
- Gaurav Hiranandani (invited) - Senior Associate Chief Accountant, U.S. Securities and Exchange Commission
- Nellie Debbeler (invited) - Deputy Technical Director, Financial Accounting Standards Board
Strategic financial stewardship
Regulatory excellence and compliance
Digital/technology-driven transformation in accounting
Evolving leadership responsibilities and priorities
- Matthew Busch - Chief Accounting Officer, Amgen
- Erin Burkhart - Group Vice President and Chief Accounting Officer, BioMarin Pharmaceutical
- Scott Godsoe - Executive Director, Assistant Corporate Controller, Vertex Pharmaceuticals
This session, featuring panelists from roles like CFO, Controller, CAO, and Treasurer will cover discussion elements on:
Their career journeys and the future-proof skill set, and experience needed for advancement
Key moments and talent development strategies within their organizations
- Doreen Levine - Americas Financial Accounting Advisory Services Health Sciences & Wellness Leader, Ernst & Young
- Kevin MacKay - Vice President, Global Technical Accounting Advisory Services & Policy, Pfizer
Revenue Recognition
Inventory Management
Cost Accounting
R&D Expense Transition
FP&A
Internal Controls and Compliance
Systems & Infrastructure
Tax Considerations
Financial Statement Presentation
Investor Relations
Biotech Funding Landscape Evolution
Portfolio Optimization Across Development Stages
M&A and Licensing Strategy
R&D Investment Analysis
Regulatory Capital Requirements
Next-Generation Financial Technologies
Digital Health Investment Opportunities
- R.J. Forbes - Senior Director, Corporate Finance and Investment Banking, Eli Lilly & Company
- Lori Macomber - Chief Financial Officer, Karyopharm Therapeutics